Daniel R. Chevallard Insider Profile
11 Followers
Daniel R. Chevallard, CFO at Regulus, holds 12.89K shares in LENZ Therapeutics (Ticker: LENZ), holds 102.31K shares in Viracta Therapeutics (Ticker: VIRX), holds 77.87K shares in Regulus (Ticker: RGLS). Most recently, Daniel R. Chevallard Bought ― shares of LENZ Therapeutics on Mar 30, 2026 for an estimated value of $64.28K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-8.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel R. Chevallard's holdings
Insider Roles
CFO
Roles that Daniel R. Chevallard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel R. Chevallard
Daniel R. Chevallard's Trading History
Regulus
Jul 02, 2019
―
Uninformative Sell
3.50K
$635.42K
Viracta Therapeutics
Feb 27, 2024
―
Uninformative Buy
2.44K
$1.02K
LENZ Therapeutics
Mar 30, 2026
CFO
Informative Buy
64.28K
$120.87K
List of latest transactions for each holding click on a transaction to see Daniel R. Chevallard's performance on stock
You May Also Like
Daniel R. Chevallard insider profile FAQ
What is the percentage of profitable transactions made by Daniel R. Chevallard?
The percentage of profitable transactions made by Daniel R. Chevallard is 50%.
What is the average return per transaction made by Daniel R. Chevallard?
The average return per transaction made by Daniel R. Chevallard is -8.50%.
What stocks does Daniel R. Chevallard hold?
Daniel R. Chevallard holds: RGLS, VIRX, LENZ stocks.
What was Daniel R. Chevallard’s latest transaction?
Daniel R. Chevallard latest transaction was an Informative Buy of $64.28K.
What was Daniel R. Chevallard's most profitable transaction?
Daniel R. Chevallard’s most profitable transaction was an Informative Buy of LENZ stock on May 15, 2024. The return on the trade was 72.60%.
What is Daniel R. Chevallard's role in Regulus?
Daniel R. Chevallard's role in Regulus is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.